Delivery Order SPE2DB24D3013-SPE2DB25FFLKC
Award Date
5/1/25
Potential Completion Date
5/2/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB24D2003|SPE2DB24FXGH7, is a Delivery Order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $31,675.65 and a period of performance through August 21, 2024. It is a Firm Fixed Price contract with no set-aside designation. AmerisourceBergen, through its Corporate Office division, has been awarded this...
This federal contract award, with an ID of SPE2DB24D2003|SPE2DB24FXDB3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $6,885.04 and a period of performance through March 7, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated....
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FB4B1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation. The contract is for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, and has a ceiling value of $4,301.61. It is a Firm Fixed Price contract that runs through March 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corporation is a major pharmaceutical distributor and healthcare solutions...
This federal contract award, with ID SPE2DB24D3015|SPE2DB25FFXXB, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has a ceiling value of $12,471.00 and is a Firm Fixed Price Delivery Order for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This federal contract award, with ID SPE2DB22D2009|SPE2DB25FL8XX, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $12,622.90 and an ultimate completion date of April 24, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, with ID SPE2DB20D3303|SPE2DB25FZ5W6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, and has a ceiling value of $2,720.90. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date...
This federal contract award, with ID SPE2DB24D2205|SPE2DB25FDZAC, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a medical product, with a ceiling value of $8,841.51 and a completion date of March 3, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type. It is not designated as a set-aside contract....
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FAJD6, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,928.18, is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 6, 2025. It is not designated as a set-aside...
This federal contract award, valued at $2,739.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with an ultimate completion date of November 7, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This contract award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $2,956.76 and a completion date of March 11, 2025. The contract is a delivery order with a firm fixed price pricing type. The award does not have a set-aside designation, indicating open competition....